title: [Cardiovascular prevention with peripheral artery disease].
abstract: Peripheral artery disease is a global disease. When present, the occurrence of cardiovascular events and death rises. Patients suffering from peripheral artery disease belong to the high CV risk category. Based on the prevention recommendations when PAD is present, treatments with and without medicine are equally necessary. A change in life-style, blood pressure reduction, diabetes mellitus treatment, reaching the target cholesterol values, treatments with ACE inhibitor, statin and thrombocyte inhibitor all lower the occurrence of CV events. The early identification of the Doppler index can help in the early diagnosis of atherothrombosis.
authors.affiliation: Fovárosi Onkormányzat Szent István Kórház és Rendelointézet, I Belgyógyászati-Kardiológiai Osztály, Budapest, Hungary. avertes@t-online.hu
authors.forename: András
authors.initials: A
authors.lastname: Vértes
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000000981:diagnostic imaging / Q000209:etiology* / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy; D008019:Life Style; D016491:Peripheral Vascular Diseases / Q000150:complications*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D040242:Risk Reduction Behavior; D018608:Ultrasonography, Doppler
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors